Wilson's disease is a rare and serious genetic disorder affecting copper metabolism in the body, leading to excessive accumulation of copper in the liver, brain, and other organs. This can cause a wide range of serious health problems, including liver cirrhosis, neurological problems, and kidney disease. Wilson's disease is caused by a genetic defect which affects the transport of copper in the body. Individuals with this disorder have a genetic mutation which means their liver is unable to excrete copper effectively. This leads to a build up of copper in the body, and it accumulates to toxic levels in certain organs. Even though Wilson's disease is a rare condition, its diagnosis can be improved through screening for genetic mutations associated with this disorder. In such cases, early diagnosis with the right treatment can be curative and the prognosis is often good. Treatment typically involves the use of medications which prevent the absorption of copper from food and chelation therapy, in which drugs bind to copper in the body so it can be eliminated in the urine. Lifestyle changes may also be beneficial, such as avoiding foods high in copper content, Vitamins C and B6, caffeine, and alcohol, as well as exercising regularly and avoiding extreme stress. Living with Wilson's disease can be challenging, as it can lead to severe physical and psychological effects. Many people with this condition, however, live normal and productive lives with the help of continuous medication, nutrition, and medication monitoring. Overall, Wilson's disease is a rare but serious disorder, but with the right treatment and support, it can be managed to maintain a healthy, happy life.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States